UB Paderborn / Katalog / Suche / in CDI

1 – 23 von 23

Sortiert nach

Malaria vaccine R&D in the Decade of Vaccines: Breakthroughs, challenges and opportunities

Vaccine, 2013-04, Vol.31, p.B233-B243

2013

Volltextzugriff (PDF)

Safety and efficacy of the RTS,S/AS01E candidate malaria vaccine given with expanded-programme-on-immunisation vaccines: 19 month follow-up of a randomised, open-label, phase 2 trial

The Lancet infectious diseases, 2011-10, Vol.11 (10), p.741-749

2011

Volltextzugriff (PDF)

Design of a phase III multicenter trial to evaluate the efficacy of the RTS,S/AS01 malaria vaccine in children across diverse transmission settings in Africa

Malaria journal, 2011-08, Vol.10 (1), p.224-224, Article 224

2011

Volltextzugriff (PDF)

Insights into long-lasting protection induced by RTS,S/AS02A malaria vaccine: further results from a phase IIb trial in Mozambican children

PloS one, 2009-04, Vol.4 (4), p.e5165-e5165

2009

Volltextzugriff (PDF)

Modeling the public health impact of malaria vaccines for developers and policymakers

BMC infectious diseases, 2013-07, Vol.13 (1), p.295-295, Article 295

2013

Volltextzugriff (PDF)

A Phase 3 Trial of RTS,S/AS01 Malaria Vaccine in African Infants

The New England journal of medicine, 2012-12, Vol.367 (24), p.2284-2295

2012

Volltextzugriff (PDF)

A research agenda for malaria eradication: vaccines

PLoS medicine, 2011-01, Vol.8 (1), p.e1000398-e1000398

Vaccines, Consultative

2011

Volltextzugriff (PDF)

Vaccines today, vaccines tomorrow: a perspective

Clinical and experimental vaccine research (Seoul), 2013-01, Vol.2 (1), p.4-7

Loucq, Christian

2013

Volltextzugriff (PDF)

First Results of Phase 3 Trial of RTS,S/AS01 Malaria Vaccine in African Children

The New England journal of medicine, 2011-11, Vol.365 (20), p.1863-1875

2011

Volltextzugriff (PDF)

Development of a transmission-blocking malaria vaccine: Progress, challenges, and the path forward

Vaccine, 2014-09, Vol.32 (43), p.5531-5539

2014

Volltextzugriff (PDF)

Roadmap for the international collaborative epidemiologic monitoring of safety and effectiveness of new high priority vaccines

Vaccine, 2013-08, Vol.31 (35), p.3623-3627

2013

Volltextzugriff (PDF)

Four year immunogenicity of the RTS,S/AS02 A malaria vaccine in Mozambican children during a phase IIb trial

Vaccine, 2011-08, Vol.29 (35), p.6059-6067

2011

Volltextzugriff (PDF)

Malaria vaccine R&D in the Decade of Vaccines: Breakthroughs, challenges and opportunities: Decade of Vaccines

Vaccine, 2013, Vol.31

2013

Volltextzugriff (PDF)

Development of standardized laboratory methods and quality processes for a phase III study of the RTS, S/AS01 candidate malaria vaccine

Malaria journal, 2011-08, Vol.10 (1), p.223-223, Article 223

2011

Volltextzugriff (PDF)

Safety, immunogenicity and duration of protection of the RTS,S/AS02(D) malaria vaccine: one year follow-up of a randomized controlled phase I/IIb trial

PloS one, 2010-11, Vol.5 (11), p.e13838

2010

Volltextzugriff (PDF)

Safety, Immunogenicity and Duration of Protection of the RTS,S/AS02D Malaria Vaccine: One Year Follow-Up of a Randomized Controlled Phase I/IIb Trial

PloS one, 2010-11, Vol.5 (11), p.e13838

2010

Volltextzugriff (PDF)

Producing a successful malaria vaccine: innovation in the lab and beyond

Health affairs (Millwood, Va.), 2011-06, Vol.30 (6), p.1065-1072

2011

Volltextzugriff (PDF)

Aligning new interventions with developing country health systems: Target product profiles, presentation, and clinical trial design

Global public health, 2012-10, Vol.7 (9), p.931-945

2012

Volltextzugriff (PDF)

Safety, Immunogenicity and Duration of Protection of the RTS,S/AS02.sub.D Malaria Vaccine: One Year Follow-Up of a Randomized Controlled Phase I/IIb Trial

PloS one, 2010-11, Vol.5 (11), p.e13838

2010

Volltextzugriff (PDF)

Four year immunogenicity of the RTS,S/AS02 sub(A) malaria vaccine in Mozambican children during a phase IIb trial

Vaccine, 2011-08, Vol.29 (35), p.6059-6067

2011

Volltextzugriff (PDF)

Four year immunogenicity of the RTS,S/AS02A malaria vaccine in Mozambican children during a phase IIb trial

Vaccine, 2011, Vol.29 (35), p.6059-6067

2011

Volltextzugriff (PDF)

Safety and efficacy of the RTS,S/AS01 sub(E) candidate malaria vaccine given with expanded-programme-on-immunisation vaccines: 19 month follow-up of a randomised, open-label, phase 2 trial

The Lancet infectious diseases, 2011-10, Vol.11 (10), p.741-749

2011

Volltextzugriff (PDF)

Safety and efficacy of the RTS,S/AS01 E candidate malaria vaccine given with expanded-programme-on-immunisation vaccines: 19 month follow-up of a randomised, open-label, phase 2 trial

The Lancet infectious diseases, 2011-10, Vol.11 (10), p.741-749

2011

Volltextzugriff (PDF)

1 – 23 von 23

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(23)
Mit Volltextzugriff
(22)

Publikationsform

Artikel
(23)

Sprache

Englisch
(23)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Malaria vaccine R&D in the Decade of Vaccines: Breakthroughs, challenges and opportunities

Safety and efficacy of the RTS,S/AS01E candidate malaria vaccine given with expanded-programme-on-immunisation vaccines: 19 month follow-up of a randomised, open-label, phase 2 trial

Design of a phase III multicenter trial to evaluate the efficacy of the RTS,S/AS01 malaria vaccine in children across diverse transmission settings in Africa

Insights into long-lasting protection induced by RTS,S/AS02A malaria vaccine: further results from a phase IIb trial in Mozambican children

Modeling the public health impact of malaria vaccines for developers and policymakers

A Phase 3 Trial of RTS,S/AS01 Malaria Vaccine in African Infants

A research agenda for malaria eradication: vaccines

Vaccines today, vaccines tomorrow: a perspective

First Results of Phase 3 Trial of RTS,S/AS01 Malaria Vaccine in African Children

Development of a transmission-blocking malaria vaccine: Progress, challenges, and the path forward

Roadmap for the international collaborative epidemiologic monitoring of safety and effectiveness of new high priority vaccines

Four year immunogenicity of the RTS,S/AS02 A malaria vaccine in Mozambican children during a phase IIb trial

Malaria vaccine R&D in the Decade of Vaccines: Breakthroughs, challenges and opportunities: Decade of Vaccines

Development of standardized laboratory methods and quality processes for a phase III study of the RTS, S/AS01 candidate malaria vaccine

Safety, immunogenicity and duration of protection of the RTS,S/AS02(D) malaria vaccine: one year follow-up of a randomized controlled phase I/IIb trial

Safety, Immunogenicity and Duration of Protection of the RTS,S/AS02D Malaria Vaccine: One Year Follow-Up of a Randomized Controlled Phase I/IIb Trial

Producing a successful malaria vaccine: innovation in the lab and beyond

Aligning new interventions with developing country health systems: Target product profiles, presentation, and clinical trial design

Safety, Immunogenicity and Duration of Protection of the RTS,S/AS02.sub.D Malaria Vaccine: One Year Follow-Up of a Randomized Controlled Phase I/IIb Trial

Four year immunogenicity of the RTS,S/AS02 sub(A) malaria vaccine in Mozambican children during a phase IIb trial

Four year immunogenicity of the RTS,S/AS02A malaria vaccine in Mozambican children during a phase IIb trial

Safety and efficacy of the RTS,S/AS01 sub(E) candidate malaria vaccine given with expanded-programme-on-immunisation vaccines: 19 month follow-up of a randomised, open-label, phase 2 trial

Safety and efficacy of the RTS,S/AS01 E candidate malaria vaccine given with expanded-programme-on-immunisation vaccines: 19 month follow-up of a randomised, open-label, phase 2 trial

Suchergebnisse filtern